Latest Breaking News On - Innovation unit communications - Page 1 : comparemela.com

Boehringer Ingelheim and IBM Collaborate to Advance Generative AI and Foundation Models for Therapeutic Antibody Development

Boehringer Ingelheim and IBM announced an agreement that will enable Boehringer to use IBM’s foundation model technologies to discover novel candidate antibodies for the development of efficient therapeutics.

Andrew nixonKatia moskvitchBoehringer ingelheimMarie ann maushartAlessandro curioniReinhard malinResearch europeBoehringer ingelheim corporate affairsAnimal healthInnovation unit communicationsHead of communicationsGlobal headVice president accelerated discoveryHuman pharmaRed hat openshiftBoehringer ingelheim

Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies

Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

Rheinland pfalzReinhard malinEngagers tcesDamian oconnellCliver woodAgency for scienceJapan corporate news networkInnovation unit communicationsResearch partnersBoehringer ingelheimTechnology organisationExperimental drug development centreGenome institute of singaporeSingapore gastric cancer consortiumCorporate communicationsAnimal health

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Boehringer ingelheimReinhard malinEngagers tcesBiophotonics bioimagingDamian oconnellCliver woodAgency for scienceInnovation unit communicationsResearch partnersTechnology organisationExperimental drug development centreGenome institute of singaporeSingapore gastric cancer consortiumExperimental biotherapeutics centreExperimental therapeutics centreCorporate communications

Boehringer Ingelheim: BOEHRINGER INGELHEIM ENTERS GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE INNOVATIVE ANTIBODIES FROM A*STAR FOR TARGETED CANCER THERAPIES

Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies These engineered antibodies may allow for

Reinhard malinDamian oconnellCliver woodAgency for scienceInnovation unit communicationsBoehringer ingelheimGenome institute of singaporeExperimental drug development centreSingapore gastric cancer consortiumCorporate communicationsInstitute of bioengineering bioimagingCorporate affairsAntibody drug conjugateSenior corporate vice presidentGlobal headDiscovery research

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Boehringer ingelheimReinhard malinEngagers tcesDamian oconnellCliver woodAgency for scienceInnovation unit communicationsResearch partnersTechnology organisationExperimental drug development centreGenome institute of singaporeSingapore gastric cancer consortiumCorporate communicationsAnimal healthInstitute of bioengineering bioimagingCorporate affairs